ZYDUSLIFE

Zydus Life ; Co Gets USFDA Final Approval for Ammonium Lactate Cream 12% • 🇺🇸 Regulatory Win: Receives final USFDA approval for Ammonium Lactate Cream 12% (generic of Lac-Hydrin). • 🧴 Product Use: Topical prescription cream used for treatment of dry, scaly skin conditions. • 🏭 Made in India: Product to be manufactured at Changodar, Ahmedabad facility. • 💰 Market Opportunity: US annual sales estimated at ~USD 15 million (IQVIA data). • 📈 Pipeline Strength: Total USFDA approvals rise to 430, with 505+ ANDA filings. 🟢 Impact: Positive Strengthens US generics portfolio, adds incremental revenue opportunity, and reinforces regulatory execution track record.